EGFR and head and neck squamous cell carcinoma: Acquisition of oncogenic action on the cell cycle (G1-S-specific cyclinD1), epidermal growth factor receptor (EGFR), and survival have also been documented in some subsets of HPV-negative HNSCC [2,6].